FOURTH AMENDMENT TO CREDIT AGREEMENTCredit Agreement • February 28th, 2017 • Emergent BioSolutions Inc. • Pharmaceutical preparations • New York
FIFTH AMENDMENT, LIMITED WAIVER AND CONSENT TO CREDIT AGREEMENTCredit Agreement • February 28th, 2017 • Emergent BioSolutions Inc. • Pharmaceutical preparations • New York
This FIFTH AMENDMENT, LIMITED WAIVER AND CONSENT TO CREDIT AGREEMENT, dated as of November 30, 2016 (this "Amendment"), modifies that certain Credit Agreement, dated as of December 11, 2013 (as amended, restated, extended, supplemented or otherwise modified in writing from time to time, the "Credit Agreement"), among EMERGENT BIOSOLUTIONS INC., a Delaware corporation (the "Borrower"), each Domestic Subsidiary of the Borrower from time to time party thereto as a Guarantor, each lender from time to time party thereto (collectively, the "Lenders" and individually, a "Lender"), and BANK OF AMERICA, N.A., as administrative agent (in such capacity, the "Administrative Agent"), Swing Line Lender and L/C Issuer. Capitalized terms used herein and not defined shall have the meaning assigned to such terms in the Credit Agreement.
